Isolated lung perfusion with FUDR in the rat: Pharmacokinetics and survival

Annals of Thoracic Surgery

Volumn 62, Issue 3, 1996, Pages 848-852

  Port, Jeffrey L ^a   Ng, Bruce ^a   Ellis, Jennifer L ^a   Nawata, Sumihiko ^a   Lenert, Jeffrey T ^a   Burt, Michael E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL MODEL; COLORECTAL CANCER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LUNG PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

EID: 0030248079     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00508-5     Document Type: Article

References (18)

1. 1. Wingo P, Tong T, Bolden S. Cancer statistics, 1995. Cancer Stat 1995;45:8-30.
2. 2. August D, Ottow R, Sugarbaker P. Clinical perspective of human colorectal cancer metastasis. Cancer Metast Rev 1984;3:303-24.
3. 3. Moertel C. Clinical management of advanced gastrointestinal cancer. Cancer 1975;36:675-82.
4. 4. Mountain C, Khalil K, Hermes K, Frazier O. The contribution of surgery to the management of carcinomatous pulmonary metastases. Cancer 1978;41:833-40.
5. 5. McAfee M, Allen M, Trastek V, Ilstrup D, Deschamps C, Pairolero P. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992;53:780-6.
6. 6. Brister S, de Varennes B, Gordon P, Sheiner N, Pym J. Contemporary operative management of pulmonary metastases of colorectal origin. Dis Colon Rectum 1988;31:786-92.
7. 7. McCormack P, Burt M, Bains M, Martini N, Rusch V, Ginsberg R. Lung resection for colorectal metastases. Arch Surg 1992;127:1403-6.
8. 8. Weksler B, Schneider A, Ng B, Burt M. Isolated single lung perfusion in the rat: an experimental model. J Appl Physiol 1993;74:2736-9.
9. 9. Weksler B, Lenert J, Ng B, Burt M. Isolated lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg 1994;107:50-4.
10. 10. Port J, Hochwald S, Wang H, Burt M. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin. Ann Thorac Surg 1995;60:239-44.
11. 11. Weksler B, Ng B, Lenert J, Burt M. A simplified method for endotracheal intubation in the rat. J Appl Physiol 1994;76: 1823-5.
12. 12. Freireich E, Gehan E, Rall D, Schmidt L, Skipper H. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;50:219-44.
13. 13. Smith-Rogers J, Tong W, Duafala M, Markman M, Bertino J. High-performance liquid Chromatographic method for the simultaneous measurement of floxuridine and fluorouracil in human body fluids. J Chromatogr 1991;566:147-54.
14. 14. Hine K, Dykes P. Prospective randomized trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA. Gut 1984;25:682-8.
15. 15. Handschumacher R, Cheng Y. Purine and pyrimidine antimetabolites. In: Cancer medicine. Philadelphia: Lea & Febiger, 1995:712.
16. 16. Ansfield F, Klotz J, Nealon T, et al. A phase III study comparing the clinical utility of four regimens of 5-flourouracil. Cancer 1977;39:34-40.
17. 17. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459-65.
18. 18. Foth H, Hellkamp J, Kunellis E, Kahl G. Pulmonary elimination and metabolism of 5-fluoro-2′-deoxyuridine in isolated perfused rat lung slices. Drug Metab Dispos 1990;18: 1011-7.